Please login to the form below

Not currently logged in
Email:
Password:

Johnson and Johnson’s second-in-command announces retirement plans

Sandra Peterson departs at the start of October

Sandra PetersonJohnson and Johnson is to say goodbye to its group worldwide chair Sandra Peterson, as the second-in-command leader will retire from her post from 1 October.

Peterson has held the role for six years, during which time she oversaw the company’s global operating infrastructure, implemented innovation and growth initiatives and supervised the consumer-facing businesses, the latter generating around £18bn in revenue for the company.

She was also tasked with getting that particular division back on track after J&J was plagued by a series of recalls, including 200,000 bottles of children’s cough drop medicine that was deployed in the US.

Peterson has also led J&J’s efforts in healthcare technology, leveraging design thinking to create solutions for patients, consumers and providers.

J&J says that after her departure, her responsibilities will be shared between Joaquin Duato, who has been leading the company’s pharmaceutical business and chief scientific officer Paul Stoffels.

Additional changes will see Jennifer Taubert succeed Duato, taking the helm of J&J’s global pharmaceutical business while Ashley McEvoy - who rejuvenated its eye-care business - will manage J&J’s group of medical device companies.

Finally, Kathy Wengel, who oversees the company’s manufacturing and Michael Sneed, chief communication officer, has been promoted to join J&J’s executive team, these moves taking place from 2 July.

Article by
Gemma Jones

25th June 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics